Clinical Research

Category IX: Clinical Research
Upper Gastrointestinal (GI) Morbidity and Gastric Acid–Reducing Agent (GARA) Use Among Oncolytic-Treated Patients with Non-Hodgkin Lymphomas: Nursing Perspective Insights
November 2022 Vol 13, No 11
To evaluate the epidemiology of upper GI morbidity, peptic ulcer risk, and prescription GARA use among patients with MCL or CLL/SLL and provide the nursing perspective on GARA use in oncology patient care.
Patient-Reported Outcomes from the Phase 3, Randomized Study of Acalabrutinib with or without Obinutuzumab versus Chlorambucil plus Obinutuzumab for Treatment-Naive Chronic Lymphocytic Leukemia (ELEVATE-TN)
P Walker , JP Sharman, W Jurczak, T Munir, V Banerji, S Coutre, JA Woyach, G Salles, WG Wierda, P Patel, MH Wang, U Emeribe, E Flood, JC Byrd, P Ghia
December 2021 Vol 12, No 12
Nursing Experience in Patients with Chronic Lymphocytic Leukemia Receiving First-Line Ibrutinib: Up to 7 Years of Follow-Up from the Phase 3 RESONATE-2 Study
Cara McGowan, NP, Jillian Settlemire, RN, Anita Szoke, MD, Gabriel Krigsfeld, PhD, Steven Coutre, MD, Paul Barr, MD
December 2021 Vol 12, No 12
Mapping the PIK3CA-Related Overgrowth Spectrum Patient and Caregiver Journey Using a Patient-Centered Approach
Dawn Aubel, EdD, MPH, APNc, Lara Rodríguez-Laguna, PhD, Kristen Davis, BS, Mellenee Finger, Robin Vlamis, MPH, CHES, Craig Johnson, DO
December 2021 Vol 12, No 12
Impact of Age on Efficacy and Safety of Relugolix: A Subgroup Analysis from the Randomized, Phase 3 HERO Study versus Leuprolide in Men with Advanced Prostate Cancer
Michael S. Cookson, MD, MMHC, Neal D. Shore, MD, Daniel J. George, MD, Hideyuki Akaza, MD, Daniel R. Saltzstein, MD, Ronald Tutrone, MD, Alberto Bossi, MD, Bruce Brown, MD, Bryan Selby, MS, Sophia Lu, PhD, Jackie Walling, MBChB, PhD, Bertrand Tombal, MD, PhD, Fred Saad, MD
December 2021 Vol 12, No 12
Expert Guidance Based on Clinical Experience of Tepotinib Side Effect Management in Patients with NSCLC Harboring MET Exon 14 Skipping
Terri Alexander, MSc
December 2021 Vol 12, No 12
Expanding the Way We Screen for Cancer: A Path to a Multicancer Early Detection Test
Tomasz M. Beer, Charles H. McDonnell, III, Lincoln Nadauld, Minetta C. Liu, Eric A. Klein, Robert Reid, Catherine R. Marinac, Karen C. Chung, Margarita Lopatin, Eric T. Fung, Deborah Schrag
December 2021 Vol 12, No 12
Characterization of Adverse Reactions in Patients with Advanced Endometrial Cancer (aEC) Receiving Lenvatinib + Pembrolizumab (Study 309/KEYNOTE-775): Nurse Roles in Patient Education and Adverse-Reaction Management
Giorgia Villa, Nicoletta Colombo, Melissa Zale, Min Ren, Lea Dutta, Vicky Makker, Vania Hom
December 2021 Vol 12, No 12
Characterization and Management of Gastrointestinal and Skin Toxicities with Mobocertinib in EGFR Exon 20 Insertion+ Non–Small-Cell Lung Cancer
Kelly Goodwin, NP
December 2021 Vol 12, No 12
Adherence to Injectable and Oral Hormone Therapies in Advanced Prostate Cancer as Measured by Proportion of Days Covered
Tao Jiang, Robert Dufour, Eddie Li, Janis Pruett
December 2021 Vol 12, No 12
Loading More Articles
Page 1 of 6
Results 1 - 10 of 60

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country
SUBSCRIBE

Contact Us | Editorial Board

© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators® PO Box 563, Cranbury, NJ 08512